On 23 May 2014, Sweden announced that it has initiated proceedings before the Court of Justice of the European Union against the Commission for failing to specify scientific criteria for the determination of endocrine-disrupting properties under Regulation 528/2012 concerning the making available on the market and use of biocidal products. Under Article 5(3) of the Regulation, the Commission’s deadline to adopt delegated acts specifying such scientific criteria was 13 December 2013. If a substance has endocrine disrupting properties according to these scientific criteria, Article 5 (1) (d) of the Regulation provides that it must not be approved.

The Official Press Release from the Swedish government can be accessed here